“

One of the notable things is that only two of these patients got these drugs as part of a clinical trial. The rest of them were given the drugs off label -- since these drugs are generally available that's at the discretion of the treating provider, but it's still notable, patients with all levels of severity of Covid-19 received these drugs, although certainly the patients that were hospitalized were more likely to receive these drugs.